ASX-Dividend-Report-Banner

6th Asia Pacific Chemsex Symposium (APCS) 2024 Opens in Bangkok with Over 300 Participants and Launch of the Gilead HIV Community Scholarship Program

November 05, 2024 02:00 PM AEDT | By Cision
 6th Asia Pacific Chemsex Symposium (APCS) 2024 Opens in Bangkok with Over 300 Participants and Launch of the Gilead HIV Community Scholarship Program
Image source: Kalkine Media

BANGKOK, Nov. 5, 2024 /PRNewswire/ -- For the first time, the Asia Pacific Chemsex Symposium (APCS) has moved from Taipei to Bangkok, marking a new chapter in its mission to expand the understanding of pleasures and harms related to chemsex in the Asia-Pacific context, and see the possibilities to optimize chemsex care. This sixth gathering of APCS, hosted by the Institute for HIV Research and Innovation (IHRI, Thailand), Service Workers in Group (SWING, Thailand), the University of Malaya (Malaysia), and HIV Education and Research Taiwan (HEArT, Taiwan), has attracted more than 300 participants and features the theme "Pleasures, Policies, and Possibilities." The symposium has become an essential forum for engaging diverse voices and discussing the unique complexities of chemsex in the region.

Dr. Stephane Wen-Wei Ku, HIV Education and Research (HEArT), Taiwan; Khun Surang Janyam, Service Workers in Group (SWING), Thailand; Dr. Nittaya Phanuphak, Institute of HIV Research and Innovation (IHRI), Thailand; and Dr. Iskandar Raja Azwa, University of Malaya, Malaysia.
Dr. Stephane Wen-Wei Ku, HIV Education and Research (HEArT), Taiwan; Khun Surang Janyam, Service Workers in Group (SWING), Thailand; Dr. Nittaya Phanuphak, Institute of HIV Research and Innovation (IHRI), Thailand; and Dr. Iskandar Raja Azwa, University of Malaya, Malaysia.

Since its inception in 2019, APCS has brought together community members, healthcare professionals, CSOs/NGOs, advocates, researchers, policymakers, donors and technical  agencies, providing a safe, culturally sensitive space to discuss issues around HIV, mental health, and harm reduction. This year's discussions focus on advancing HIV/STI prevention, improving mental health, and promoting evidence-based, rights affirming chemsex harm reduction interventions and policies tailored to the needs of key populations.

"A core goal of APCS is to empower and facilitate community leaders and stakeholders to collaborate and share resources across borders," said Dr. Nittaya Phanuphak, Convenor of APCS 2024 Organizing Committee. "We aim to spotlight initiatives that respect the diverse  social dynamics and policy environments across the region to minimize harm and foster impactful change."

A major highlight of this year's symposium is the launch of the Gilead HIV Community Scholarship Program, an initiative that recognizes the vital work of community-based organizations (CBOs) in chemsex-related harm reduction, HIV prevention, and community care. This program supports and amplifies the voices of those who are closest to the communities affected by chemsex and HIV.

The HIV Community Scholars, supported by Gilead Sciences, are invited to attend APCS 2024 to present their innovative projects and exchange learnings and ideas with like-minded peers and experts. Key projects presented include:

  • Abstract #27016: "High, Fun, and Safe: A Community-Centered HIV and Harm Reduction Intervention for the MSM Chemsex Community in Vietnam" by Phung Ba Thanh from Vietnam's Lighthouse organization. This oral presentation focuses on an HIV and harm reduction intervention tailored to the needs of MSM communities engaged in chemsex.
  • Abstract #30128: "Walking on Eggshells: Experiences and Perceptions Towards Accessing HIV Services Among Filipino MSM Engaged in Chemsex during the Philippines' War on Drugs" by Rodenie Arnaiz Olete and Kate Leyritana. This poster sheds light on the challenges Filipino MSM face in accessing HIV services amid stigma, emphasizing the development of culturally tailored resources to address local needs
  • Abstract #35077: "Successes and Challenges in Piloting Screening, Brief Intervention, and Referral to Treatment (SBIRT) Services for Sexualized Drug Users Among Young Key Populations in Yangon, Myanmar" led by Myo Myat Aung and a Myanmar-based team. This poster presentation emphasizes peer support and harm reduction strategies for young people in Yangon.

"Community-based organizations are in the frontline of addressing HIV prevention and harm reduction," said Alain Chan, Executive Director, Medical Affairs of Gilead Patient Solutions. "We're proud to see the launch of the Gilead HIV Community Scholars Program, honoring our community partners through supporting their travel to participate in the APCS. We hope they can leverage this opportunity to learn and exchange and be inspired by each other."

The APCS 2024 symposium will continue through November 7 at the Benjasiri Ballroom 1-3, 5th Floor, Novotel Sukhumvit 20, with discussions on the latest research, policy initiatives, and community-driven solutions for chemsex-related health challenges in the Asia-Pacific region.

For media inquiries, please contact:
Phat Parkpien, Consultant, APCO
[email protected]
Tel: 081 858 6376

About Asia Pacific Chemsex Symposium (APCS)
APCS is an annual event dedicated to fostering meaningful dialogues, sharing valuable insights, and encouraging collaboration to tackle the complex, locally relevant challenges of Chemsex. Our focus includes key populations, HIV/STI prevention, mental health, and harm reduction. Join us in this important endeavor to make a difference. Our collaborators include Institute for HIV Research and Innovation (IHRI, Thailand), Service Workers in Group (SWING, Thailand), the University of Malaya (Malaysia), and HIV Education and Research Taiwan (HEArT, Taiwan).

About Gilead HIV Community Scholarship Program
The Gilead HIV Community Scholars Program aims to empower community-based organizations (CBOs) dedicated to HIV prevention and harm reduction. By providing scholarships to select scholars, the program highlights the vital role these organizations play in addressing the complexities of HIV care, particularly among key populations. Scholars will have the opportunity to attend the Asia-Pacific Chemsex Symposium, where they can share their innovative work, engage with experts, and collaborate with peers committed to advancing HIV care and support in their communities.

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.